Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl cysteine as adjunctive therapy for painful diabetic neuropathy
IRCT20150629022965N19Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetylcysteine in diabetic polyneuropathy (DPN) and diabetic neuropathy, sponsored by Hamadan University of Medical Sciences. Primary endpoints: Pain intensity reduction and Serum oxidative stress biomarkers. Started Aug 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
diabetic polyneuropathy (DPN)diabetic neuropathy
Beyond the preview
Go deeper on IRCT20150629022965N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150629022965N19.